Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


Lab-on-a-Chip Asia

20 Nov 2014 - 21 Nov 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is pleased to present the second annual Lab-on-a-Chip Asia conference and exhibition, focusing on Microfluidic technologies with particular reference to Point-of-Care Diagnostics. Building on the success of last year’s event we are pleased to again be organizing the meeting in conjunction with the Singapore Institute of Manufacturing Technology (SIMTech), a globally recognized research institute of the Agency for Science and Technology Research (A*STAR). We are honoured to have Dr. Zhiping Wang, as the Conference Chairman. Dr. Wang is the Director of Research Programmes SIMTech and the SIMTech Microfluidics Foundry.


During this event, you will gain an insight into the latest developments in Microfluidics and Microfabrication, Optofluidics and Detection and Biomolecular Detection to name just a few of the exciting topics we will be covering.

In addition to the comprehensive conference programme, we will also be offering a tour of the facilities at the SIMTech Microfluidics Foundry. The tour will be hosted by Dr. Zhiping Wang and is open to all conference attendees, providing you with a detailed insight into the advanced work carried out by SIMTech.

Agenda Topics: - Biomolecular Detection - Cell Separation and Capture - Diagnostics and Medical Applications - Droplet Manipulation and Applications - Market Orientated Device Development - Microfabrication and Microfluidics Manufacturing Technology - Microfluidics Components and Devices - Nanotech on a Chip - Optofluidics and Detection - Single Cell Processing and Analysis

Further information
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!